Literature DB >> 18403645

Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma.

Yi Peng1, Jordan Laser, Guizhi Shi, Khush Mittal, Jonathan Melamed, Peng Lee, Jian-Jun Wei.   

Abstract

High-mobility group A2 (HMGA2) is commonly overexpressed in large leiomyomas. HMGA2 is an important regulator of cell growth, differentiation, apoptosis, and transformation. As a predicted target of Let-7 microRNAs (Let-7s), HMGA2 can be repressed by Let-7s in vitro. MicroRNA profiling analysis revealed that Let-7s were significantly dysregulated in uterine leiomyomas: high in small leiomyomas and lower in large leiomyomas. To evaluate whether Let-7 repression of HMGA2 plays a major role in leiomyomas, we analyzed the molecular relationship of HMGA2 and Let-7s, both in vitro and in vivo. We first characterized that exogenous Let-7 microRNAs could directly repress the dominant transcript of HMGA2, HMGA2a. This repression was also identified for two cryptic HMGA2 transcripts in primary leiomyoma cultures. Second, we found that the endogenous Let-7s were biologically active and played a major role in the regulation of HMGA2. Then, we illustrated that Let-7 repression of HMGA2 inhibited cellular proliferation. Finally, we examined the expression levels of Let-7c and HMGA2 in a large cohort of leiomyomas (n = 120), and we found high levels of Let-7 and low levels of HMGA2 in small leiomyomas, and low levels of Let-7 and high levels of HMGA2 in large leiomyomas. Our findings suggest that the Let-7-mediated repression of HMGA2 mechanism can be an important molecular event in leiomyoma growth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18403645     DOI: 10.1158/1541-7786.MCR-07-0370

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  67 in total

1.  Double-stranded Let-7 mimics, potential candidates for cancer gene therapy.

Authors:  Qi-zhao Wang; Ying-hui Lv; Yu-hua Gong; Zhao-fa Li; William Xu; Yong Diao; Ruian Xu
Journal:  J Physiol Biochem       Date:  2011-11-09       Impact factor: 4.158

2.  Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma.

Authors:  Junfang Ji; Lei Zhao; Anuradha Budhu; Marshonna Forgues; Hu-Liang Jia; Lun-Xiu Qin; Qing-Hai Ye; Jinming Yu; Xuetao Shi; Zhao-You Tang; Xin Wei Wang
Journal:  J Hepatol       Date:  2010-03-01       Impact factor: 25.083

3.  Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations.

Authors:  Jia Xie; Julianne Ubango; Yanli Ban; Debabrata Chakravarti; J Julie Kim; Jian-Jun Wei
Journal:  Genes Chromosomes Cancer       Date:  2018-08-20       Impact factor: 5.006

Review 4.  MicroRNA in the ovary and female reproductive tract.

Authors:  M Z Carletti; L K Christenson
Journal:  J Anim Sci       Date:  2008-09-12       Impact factor: 3.159

5.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

Review 6.  Minireview: The roles of small RNA pathways in reproductive medicine.

Authors:  Shannon M Hawkins; Gregory M Buchold; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2011-05-05

7.  mRNA isoform diversity can obscure detection of miRNA-mediated control of translation.

Authors:  Jennifer L Clancy; Grace H Wei; Nicole Echner; David T Humphreys; Traude H Beilharz; Thomas Preiss
Journal:  RNA       Date:  2011-04-05       Impact factor: 4.942

8.  HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes.

Authors:  Jingjing Wu; Zhaojian Liu; Changshun Shao; Yaoqin Gong; Eva Hernando; Peng Lee; Masashi Narita; William Muller; Jinsong Liu; Jian-Jun Wei
Journal:  Cancer Res       Date:  2011-01-11       Impact factor: 12.701

9.  MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.

Authors:  Nuo Yang; Sippy Kaur; Stefano Volinia; Joel Greshock; Heini Lassus; Kosei Hasegawa; Shun Liang; Arto Leminen; Shan Deng; Lori Smith; Cameron N Johnstone; Xian-Ming Chen; Chang-Gong Liu; Qihong Huang; Dionyssios Katsaros; George Adrian Calin; Barbara L Weber; Ralf Bützow; Carlo M Croce; George Coukos; Lin Zhang
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

10.  microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells.

Authors:  Qun Pan; Xiaoping Luo; Nasser Chegini
Journal:  Mol Hum Reprod       Date:  2009-11-11       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.